Kenneth T. Mills, President and CEO at REGENXBIO Inc. (RGNX), sold 6,000 shares at $40.02 ($240K) on 2021-06-24, disclosed to the SEC on 2021-06-28.
Seasonal sale ($240k) by President and CEO — this insider has traded RGNX in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.02 | 4,500 | $180K | 74.9% |
| 2 | $40.25 | 1,500 | $60K | 25.1% |
| Total | $40.08 avg | 6,000 | $240K | 100% |
| Filing → |
| RGNX | SELL | 2024-07-18 | $33K | — | Filing → |
| RGNX | SELL | 2024-05-16 | $237K | — | Filing → |
| RGNX | SELL | 2024-04-17 | $273K | — | Filing → |